PTC THERAPEUTICS, INC. — Director's Dealing 2016

Mar 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2016-03-03

Reporting Person: Rothera Mark (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-03	Common Stock	P	2000	$6.23	Acquired	5125	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9216	Indirect

Footnotes

F1: Shares held by trust of which reporting person's spouse is a beneficiary.